118 related articles for article (PubMed ID: 20102936)
1. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
[TBL] [Abstract][Full Text] [Related]
2. Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.
Freitas RAP; Tanajura LF; Mehran R; Chamié D; Chaves A; Centemero M; Braga S; Costa R; Cao D; Sousa A; Feres F; Costa JR
J Invasive Cardiol; 2023 Jun; 35(6):E281-E290. PubMed ID: 37220640
[TBL] [Abstract][Full Text] [Related]
3. Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy - a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial.
Biernacka-Fiałkowska B; Szuksztul M; Suślik W; Dzierwa K; Tekieli Ł; Kostkiewicz M; Podolec P; Pieniążek P
Postepy Kardiol Interwencyjnej; 2018; 14(1):59-66. PubMed ID: 29743905
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial.
Gholoobi A; Sajjadi SM; Shabestari MM; Eshraghi A; Shamloo AS
Electron Physician; 2015 Dec; 7(8):1557-65. PubMed ID: 26816582
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure.
Li H; Li X; Ma H; Wang Y; Fu N; Jin D; Cong H
ScientificWorldJournal; 2014; 2014():565367. PubMed ID: 24672331
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization.
Kumar A; Bhawani G; Kumari N; Murthy KS; Lalwani V; Raju ChN
J Clin Diagn Res; 2014 Dec; 8(12):HC03-7. PubMed ID: 25653965
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial to assess the potential role of ascorbic acid and statin for post-contrast acute kidney injury prevention.
Hashem A; Laymon M; Elgamal M; Hegazy M; Elmeniar AM; Refaie H; Osman Y
Int Urol Nephrol; 2024 Feb; 56(2):399-405. PubMed ID: 37742328
[TBL] [Abstract][Full Text] [Related]
8. Prospective Randomized Trial of Na/K Citrate for the Prevention of Contrast-Induced Nephropathy in High-risk Patients.
Iranirad L; Sadeghi MS; Hejazi SF
Med J Islam Repub Iran; 2024; 38():27. PubMed ID: 38783979
[TBL] [Abstract][Full Text] [Related]
9. Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.
Li JX; Jin EZ; Yu LH; Li Y; Liu NN; Dong YM; Li X; Li XQ
Exp Ther Med; 2017 Aug; 14(2):1568-1576. PubMed ID: 28810622
[TBL] [Abstract][Full Text] [Related]
10. Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.
Hung YM; Lin SL; Hung SY; Huang WC; Wang PY
World J Cardiol; 2012 May; 4(5):157-72. PubMed ID: 22655164
[TBL] [Abstract][Full Text] [Related]
11. Contrast-induced nephropathy; A literature review.
Golshahi J; Nasri H; Gharipour M
J Nephropathol; 2014; 3(2):51-6. PubMed ID: 24772397
[TBL] [Abstract][Full Text] [Related]
12. Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention.
Sterner G; Nyman U
Libyan J Med; 2007 Sep; 2(3):118-24. PubMed ID: 21503209
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Hydration and Contrast-Induced Acute Kidney Injury: Too Much of a Good Thing?
Gupta R; Moza A; Cooper CJ
J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27233299
[No Abstract] [Full Text] [Related]
14. Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
Ozhan H; Erden I; Ordu S; Aydin M; Caglar O; Basar C; Yalcin S; Alemdar R
Angiology; 2010 Oct; 61(7):711-4. PubMed ID: 20395226
[TBL] [Abstract][Full Text] [Related]
15. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
16. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Han Y; Zhu G; Han L; Hou F; Huang W; Liu H; Gan J; Jiang T; Li X; Wang W; Ding S; Jia S; Shen W; Wang D; Sun L; Qiu J; Wang X; Li Y; Deng J; Li J; Xu K; Xu B; Mehran R; Huo Y
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):62-70. PubMed ID: 24076297
[TBL] [Abstract][Full Text] [Related]
17. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.
Quintavalle C; Fiore D; De Micco F; Visconti G; Focaccio A; Golia B; Ricciardelli B; Donnarumma E; Bianco A; Zabatta MA; Troncone G; Colombo A; Briguori C; Condorelli G
Circulation; 2012 Dec; 126(25):3008-16. PubMed ID: 23147173
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin and prevention of contrast induced nephropathy following coronary angiography.
Bidram P; Roghani F; Sanei H; Hedayati Z; Golabchi A; Mousavi M; Hajiannejad A; Pourheidar B; Badalabadi MM; Gharaati M; Akhbari M; Salesi A
J Res Med Sci; 2015 Jan; 20(1):1-6. PubMed ID: 25767514
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
Li H; Wang C; Liu C; Li R; Zou M; Cheng G
Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
